Efficient inhibition of human cytomegalovirus UL122 gene expression in cell by small interfering RNAs

Journal of Basic Microbiology

Volumn 49, Issue 6, 2009, Pages 531-537

  Duan, Qun Jun ^a   Tao, Ran ^a   Hu, Miao Feng ^a   Shang, Shi Qiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Human cytomegalovirus; RNA interference; Small interfering RNA; UL122 gene

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; IE2 PROTEIN, CYTOMEGALOVIRUS; IMMEDIATE EARLY PROTEIN; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; RNA INTERFERENCE;

CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENE KNOCKDOWN TECHNIQUES; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMEDIATE-EARLY PROTEINS; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSFECTION;

HUMAN HERPESVIRUS 5;

EID: 70749122163     PISSN: 0233111X     EISSN: 15214028     Source Type: Journal    
DOI: 10.1002/jobm.200800364     Document Type: Article

References (32)

1. Galiana-Arnoux, D., Dostert, C., Schneemann, A., Hoffmann, J.A. et al., 2006. Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila. Nat. Immunol., 7, 590-597.
2. Segers, G.C., Zhang, X., Deng, F., Sun, Q. et al., 2007. Evidence that RNA silencing functions as an antiviral defense mechanism in fungi. Proc. Natl. Acad. Sci. USA., 104, 12902-12906.
3. van Rij, R.P. and Andino, R., 2006. The silent treatment: RNAi as a defense against virus infection in mammals. Trends. Biotechnol., 24, 186-193.
4. Zamore, P.D., 2007. RNA silencing: genomic defence with a slice of pi. Nature, 446, 864-865.
5. Houwing, S., Kamminga, L.M., Berezikov, E., Cronembold, D. et al., 2007. A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in Zebrafish Cell, 129, 69-82.
6. Ohashi, H., Umeda, N., Hirazawa, N., Ozaki, Y. et al., 2007. Expression of vasa (vas)-related genes in germ cells and specific interference with gene functions by doublestranded RNA in the monogenean, Neobenedenia girellae. Int. J. Parasitol., 37, 515-523.
7. Flahaut, M., Muhlethaler-Mottet, A., Auderset, K., Bourloud, K.B. et al., 2006. Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells. Apoptosis, 11, 255-263.
8. Holen, T., Amarzguioui, M., Wiiger, M. T., Babaie, E. et al., 2002. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res., 30, 1757-1766.
9. Kumar, P., Ban, H.S., Kim, S.S., Wu, H. et al., 2008. T cellspecific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell, 134, 577-586.
10. Kusov, Y., Kanda, T., Palmenberg, A., Sgro, J.Y. et al., 2006. Silencing of hepatitis A virus infection by small interfering RNAs. J. Virol., 80, 5599-5610.
11. Meng, Z., Xu, Y., Wu, J., Tian, Y. et al., 2008. Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA. J. Virol. Methods, 150, 27-33.
12. Lupberger, J., Brino, L. and Baumert, T.F., 2008. RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle. J. Hepatol., 48, 523-525.
13. Tao, R., Hu, M., Duan, Q. and Shang, S., 2008. Efficient inhibition of human cytomegalovirus DNA polymerase expression by small hairpin RNA in vitro. Curr. Microbiol., DOI: 10.1007/s00284-008-9210-0.
14. Shin, M.C., Hong, S.K., Yoon, J.S., Park, S.S. et al., 2006. Inhibition of UL54 and UL97 genes of human cytomegalovirus by RNA interference. Acta. Virol., 50, 263-268.
15. Ghazal, P., Visser, A.E., Gustems, M., Garcia, R. et al., 2005. Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture. J. Virol., 79, 7182-7194.
16. Marchini, A., Liu, H. and Zhu, H., 2001. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol., 75, 1870-1878.
17. Heider, J.A., Bresnahan, W.A. and Shenk, T.E., 2002. Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein. Proc. Natl. Acad. Sci. USA, 99, 3141-3146.
18. Sanchez, V., Clark, C.L., Yen, J.Y., Dwarakanath, R. et al., 2002. Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication. J. Virol., 76, 2973-2989.
19. White, E.A., Clark, C.L., Sanchez, V. and Spector, D.H., 2004. Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J. Virol., 78, 1817-1830.
20. Su, J., Zhu, Z., Xiong, F. and Wang, Y., 2008. Hybrid cytomegalovirus-U6 promoter-based plasmid vectors improve efficiency of RNA interference in zebrafish. Mar. Biotechnol. (NY), 10, 511-517.
21. Cahill, A.L., Moore, J.M., Sabar, F.I. and Harkins, A.B., 2007. Variability in RNA interference in neuroendocrine PC12 cell lines stably transfected with an shRNA plasmid. J. Neurosci. Methods, 166, 236-240.
22. Livak, K.J. and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
23. Ter Brake, O., Legrand, N., von Eije, K.J., Centlivre, M. et al., 2008. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)(c) (-/-)) mouse model. Gene. Ther., DOI:10.1038/gt.2008.124.
24. Reynolds, A., Anderson, E.M., Vermeulen, A., Fedorov, Y. et al., 2006. Induction of the interferon response by siRNA is cell typeand duplex length-dependent. RNA., 12, 988-993.
25. Scacheri, P.C., Rozenblatt-Rosen, O., Caplen, N.J., Wolfsberg, T.G. et al., 2004. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. USA, 101, 1892-1897.
26. Snove, O., Jr. and Holen, T., 2004. Many commonly used siRNAs risk off-target activity. Biochem. Biophys. Res. Commun., 319, 256-263.
27. Brummelkamp, T.R., Bernards, R. and Agami, R., 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell, 2, 243-247.
28. Kayhan, H., Karatayli, E., Turkyilmaz, A.R., Sahin, F. et al., 2007. Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines. Arch. Virol., 152, 871-879.
29. Walchli, S. and Sioud, M., 2008. Vector-based delivery of siRNAs: in vitro and in vivo challenges. Front. Biosci., 13, 3488-3493.
30. Asokan, A., Johnson, J.S., Li, C. and Samulski, R.J., 2008. Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals. Gene. Ther., DOI:10.1038/gt.2008.127.
31. Muhonen, P., Parthasarathy, R.N., Janckila, A.J., Buki, K.G. et al., 2008. Analysis by siRNA_profile program displays novel thermodynamic characteristics of highly functional siRNA molecules. Source. Code Biol. Med., 3, 8.
32. Zhang, W., Xie, C.M. and Li, Z.P., 2007. Expression of aquaporin-1 in rat pleural mesothelial cells and its specific inhibition by RNA interference in vitro. Chin. Med. J. (Engl.), 120, 2278-2283.